Central Laboratories White Papers & Articles

  1. Accelerating Chronic Disease Clinical Study Reports With AI-Enabled Medical Writing And Expert Oversight 9/14/2026

    AI-enabled medical writing can cut clinical study report timelines by up to 70%, helping teams manage growing chronic disease trial documentation without sacrificing quality or oversight.

  2. Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually Control 9/9/2026

    This piece breaks down why Agentic AI monitoring, nearly a third of trial cost, resets the economics, and why the first CRO to move first resets the price floor for everyone else.

  3. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

    This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

  4. Why Operational Expertise Defines Great Clinical Trial Services 9/4/2026

    Great trial technology isn't enough on its own. See why the operational expertise behind it can make or break your study's success.

  5. Why Are Clinical Trial Sites Are Absorbing Increased Complexity? 9/4/2026

    Site coordinators are overwhelmed by disconnected systems. Learn how unified trial technology can ease that load and free up time for patients.

  6. Tech-Enabled FSP Delivery 8/29/2026

    Struggling with data silos and delayed trial visibility? See how combining AI with smarter data integration helps teams gain real-time visibility without adding headcount.

  7. AI in Clinical Trials: 5 Practical TrialKit Use Cases for Data Management 8/27/2026

    AI is improving daily data management with automation, faster issue detection, and smarter reviews. This piece outlines practical use cases and what teams need to enable real, sustainable adoption.

  8. From Data Capture To Clinical Intelligence: How AI Is Expanding EDC In Clinical Trials 8/27/2026

    Modern electronic data capture (EDC) systems are transforming clinical trials by evolving from data repositories into dynamic clinical intelligence hubs.

  9. Your 6-Step Path To AI-Ready Data 8/27/2026

    Struggling with siloed or inconsistent trial data? This guide outlines a clear path to cleaner, governed, AI-ready datasets.

  10. The FSP Model Tailored For Biotech 8/21/2026

    As biomarker-driven trial designs and protocol complexity intensify, small and mid-sized sponsors face a growing gap between ambition and operational capacity that fragmented outsourcing can't close.